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BACTERIORHODOPSIN-BASED SENSORS
RELATED APPLICATIONS
This application claims priority to U.S. Provisional Patent 
Application Ser. No. 60/991,060, filed Nov. 29, 2007, which 
is incorporated by reference in its entirety.
STATEMENT REGARDING FEDERALLY 
FUNDED RESEARCH
This invention was made with U.S. Government support 
under Grant No. DAAD17-03-C-0125 awarded by the United 
States Army. The U.S. Government has certain rights in the 
invention.
BACKGROUND
Bacteriorhodopsin (bR) is a retinal protein that has been 
intensely studied over the years due to its inherent ability to 
function as a light-driven proton pump. It is composed of a 
248 amino acidpeptide with a molecular weight o f26,784 Da 
and it possesses a covalently attached retinal group. Structur­
ally similar to the visual rhodopsin found in the human eye, 
bacteriorhodopsin is found in the cell membrane of Halobac- 
terium salinarium where it functions to establish a proton and 
electrochemical gradient for the synthesis of ATP under 
anaerobic/light conditions. Hampp, Chem. Rev., 100 (5), 
1755-76 (2000). Upon illumination with yellow-green light, a 
proton is pumped from the cytoplasmic side to the extracel­
lular side of the cell membrane. Hwang, J. Membrane Bio., 
33, 325-50, (1977). The charge separation resulting from the 
absorbed light appears 450 fs after the light incidence, imply­
ing the potential for a very high frequency sensor. Wang, 
Biosensors and Bioelectronics, 21, 1309-19, (2006).
For engineered applications, bacteriorhodopsin is purified 
as membrane patches, known as purple membrane (PM). 
Purple membrane is simply a laige cell membrane patch, on 
average 500 nm in diameter, which is composed of multiple 
bacteriorhodopsin molecules and their associated lipids. 
Purple membrane is composed of bacteriorhodopsin and its 
associated lipids in a two-dimensional crystal. This structure 
provides it a high degree of chemical stability and resistance 
to thermal degradation. It is called PM due to its distinct 
purple color, which is due to its absorption peak near 570 nm.
Purple membrane has many unique properties that make it 
a viable engineering material. Specifically, PM has been 
shown to maintain functionality at temperatures up to 80° C. 
in water and 140° C. dried. Hampp, Chem. Rev., 100 (5), 
1755-76 (2000). In the dried state, as well as the wet state, PM 
retains its light absorption properties and photochemical 
activity for years.
Quantum dots (QD) are semiconductor particles that have 
dimensions on the order of a few nanometers or less. When 
compared to other fluorophores, such as fluorescent dyes, 
QD’s have higher quantum yields, greater chemical stability, 
longer lifetimes, and a greater resistance to photo bleaching. 
Jovin, Nature Biotechnology, 21, 32-33 (2003). They are also 
tunable based upon dot diameter. Another important charac­
teristic is that QDs have a broad absorption range coupled 
with narrow emission spectra. The absorption spectrum for 
QDs lies primarily in the ultra-violet region while their emis­
sion range can be tuned to a very specific wavelength range. 
Medintz, Nature Materials, 2, 630-38, (2003). A QD’s emis­
sion wavelength is directly dependent upon its diameter, with 
a diameter of approximately 2 nm yielding photonic emission 
in the 570 nm range.
1
SUMMARY OF THE INVENTION
In one embodiment, the invention provides a sensor com­
prising a membrane layer, containing bacteriorhodopsin, two 
electrodes, a substrate and a circuit. The membrane layer is 
arranged between the electrodes, the electrodes being adja­
cent to the circuit such that the circuit produces a signal when 
charge is transferred through the membrane between elec­
trodes. When the membrane is exposed to visible light, a 
charge is transferred through the membrane, thus generating 
a signal in the circuit. The sensor may achieve additional 
functionality with the inclusion of fluorophores in proximity 
to the membrane. The fluorophores can absorb light and then 
transfer the energy of the light to the bacteriorhodopsin via 
radiative or non-radiative eneigy transfer. The fluorophores 
are optionally quantum dots which may be further function­
alized to modify the response of the sensor to particular 
stimuli, such as targeted chemicals or biological species. A 
plurality of sensors according to this embodiment may be 
arranged to produce a chemical or biological sensor with 
multiple sensitivities.
In another embodiment, the invention provides a sensor 
comprising a semiconductor transistor having a drain, a 
source, and a gate, and an adhesion spacer layer adjacent to 
the gate. A membrane layer, containing bacteriorhodopsin, is 
adjacent to the adhesion spacer layer. The semiconductor 
transistor is operatively connected to a circuit such that a 
change in the gate potential will produce a signal in the 
circuit. When the membrane is exposed to visible light, the 
potential at the gate of the transistor changes resulting in a 
signal in the circuit. The sensor may achieve additional func­
tionality with the attachment of fluorophores to the mem­
brane. The fluorophores can absorb light and then transfer the 
energy of the light to the bacteriorhodopsin via radiative or 
non-radiative energy transfer. The fluorophores are option­
ally quantum dots which may be further functionalized to 
modify the response of the sensor to particular stimuli, such 
as targeted chemicals or biological species. A plurality of 
sensors according to this embodiment may be arranged to 
produce a chemical or biological sensor with multiple sensi­
tivities.
In another embodiment, the invention provides a sensor 
comprising a semiconductor transistor having a drain, a 
source, and a gate, and a membrane layer, containing bacte­
riorhodopsin, adjacent to the gate. The semiconductor tran­
sistor is operatively connected to a circuit such that a change 
in the gate potential will produce a signal in the circuit. When 
the membrane is exposed to visible light, the potential at the 
gate of the transistor changes resulting in a signal in the 
circuit. The sensor may achieve additional functionality with 
the attachment of fluorophores to the membrane. The fluoro­
phores can absorb light and then transfer the energy of the 
light to the bacteriorhodopsin via radiative or non-radiative 
energy transfer. The fluorophores are optionally quantum 
dots which may be further functionalized to modify the 
response of the sensor to particular stimuli, such as targeted 
chemicals or biological species. A plurality of sensors accord­
ing to this embodiment may be arranged to produce a chemi­
cal or biological sensor with multiple sensitivities.
In another embodiment, the invention provides a method 
for detecting targeted chemical or biological species in a 
sample using a bacteriorhodopsin-based sensor according to 
the invention. The method comprises observing a first signal 
from a bacteriorhodopsin-based sensor with functionalized 
fluorophores, in the presence of light with a wavelength 
shorter than 570 nm, contacting the sensor with a sample, 
observing a second signal from the sensor, in the presence of
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light with a wavelength shorter than 570 nm, and comparing 
the first and second signals. A difference between the first and 
second signals indicates the presence of a targeted chemical 
or biological species.
In another embodiment, the invention provides a method 
for quantifying an amount of targeted chemical or biological 
species in a sample. A bacteriorhodopsin-based sensor with 
functionalized fluorophores is exposed to a plurality of cali­
brated samples of a chemical or biological species, in the 
presence of light with a wavelength shorter than 570 nm, and 
the signal from the circuit is recorded for each of the plurality 
of calibrated solutions. Using known correlation techniques, 
the signal corresponding to each of the plurality of calibrated 
samples can be correlated to an amount of targeted chemical 
or biological species in each of the plurality of calibrated 
samples. Once the bacteriorhodopsin-based sensor with func­
tionalized fluorophores is calibrated, an amount of a chemical 
or biological species can be quantified in a sample by corre­
lating the signal from the circuit to an amount of a chemical or 
biological species.
In another embodiment, the invention provides a sensor 
array comprising an array of bacteriorhodopsin-based semi­
conductor transistor sensors. Membrane layers, containing 
bacteriorhodopsin, are arranged to produce responses in the 
gates of an array of transistors, the membrane layers may be 
adjacent to the gates, or the membrane layers may be adjacent 
to adhesion spacer layers, which are adjacent to the gates. The 
membranes of the array may be further functionalized by 
attaching fluorophores to the membranes, thus allowing the 
fluorophores to radiatively or non-radiatively transfer energy 
to the membrane when the fluorophores are exposed to light. 
By adding multiple functionalities to the fluorophores, the 
array may be made simultaneously sensitive to several tar­
geted chemical or biological species.
Other aspects of the invention will become apparent by 
consideration of the detailed description and accompanying 
drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a high-level depiction of an embodiment of the 
invention.
FIG. 2 is a representation of a sensor response to a blinking 
LED.
FIG. 3 shows the spectral overlap between a fluorophore 
emission spectrum and the bacteriorhodopsin absorption 
spectrum.
FIG. 4 is a high-level depiction of another embodiment of 
the invention.
FIG. 5 is a high-level depiction of another embodiment of 
the invention.
FIG. 6 is a schematic diagram of the protocol for producing 
oriented purple membrane (PM) films.
FIG. 7 is schematic diagram of completed wet (a) and dry 
(b) PM film assemblies.
FIG. 8 is a diagram of an electronic circuit used to measure 
charge gradients.
FIG. 9 shows a wet quantum dot-bacteriorhodopsin light 
sensor, and a signal from a wet quantum dot-bacteriorhodop­
sin light sensor.
FIG. 10 is a signal from a dry quantum dot-bacteriorhodop­
sin light sensor.
FIG. 11 compares a signal from a three monolayer bacte­
riorhodopsin light sensor to a signal from a three monolayer 
bacteriorhodopsin light sensor with attached quantum dots.
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FIG. 12 shows schematic diagrams of wet and dry assem­
blies and a graph of the efficiency of non-radiant energy 
transfer as a function of distance.
FIG. 13 is a schematic diagram of the protocol for the 
construction of a maltose sensor.
FIG. 14 is a schematic diagram of an antibody sensor 
according to the invention.
FIG. 15 is a depiction of an array of sensors according to 
the invention.
DETAILED DESCRIPTION OF THE INVENTION
Before any embodiments of the invention are explained in 
detail, it is to be understood that the invention is not limited in 
its application to the details of construction and the arrange­
ment of components set forth in the following description or 
illustrated in the following drawings. The invention is capable 
of other embodiments and of being practiced or of being 
carried out in various ways. Also, it is to be understood that 
the phraseology and terminology used herein is for the pur­
pose of description and should not be regarded as limiting. 
The use of “including,” “comprising,” or “having” and varia­
tions thereof herein is meant to encompass the items listed 
thereafter and equivalents thereof as well as additional items.
The invention provides, among other things, a bacterior­
hodopsin-based sensor that can be used to sense light or 
chemical or biological targets of interest.
A high level illustration of a bacteriorhodopsin-based sen­
sor 20 is shown in FIG. 1. A layer of purple membrane 21, 
comprising bacteriorhodopsin 22 and associated lipids 23 is 
deposited on a first electrode 24 that is adjacent to a substrate 
25 which provides structural support for the sensor. A second 
electrode 26 is placed adjacent to layer of purple membrane 
21 opposite first electrode 24. In some embodiments, layer of 
purple membrane 21 may be nearby or next to second elec­
trode 26 without contacting second electrode 26. In other 
embodiments layer of purple membrane 21 may contact sec­
ond electrode 26. First electrode 24 and second electrode 26 
may be made by sputtering conductive metals or alloys, such 
as gold, silver, copper, aluminum, or indium tin oxide, onto a 
surface, or directly onto layer of purple membrane 21. Other 
methods of constructing first electrode 24 and second elec­
trode 26 are known to those of skill in the art. For example, 
electrodes may be a conductive wire (e.g., platinum) used in 
conjunction with an electrolyte (e.g., potassium chloride). 
First electrode 24 and second electrode 26 are operatively 
connected to a circuit 30, such that circuit 30 produces a 
signal when the chaige gradient between first electrode 24 
and second electrode 26 changes. As discussed above, when 
bacteriorhodopsin is exposed to light of approximately 570 
nm, a proton is pumped from the cytoplasmic side to the 
extracellular side of layer of purple membrane 21, resulting in 
a change in the charge gradient between first electrode 24 and 
second electrode 26. Accordingly, when bacteriorhodopsin- 
based sensor 20 is exposed to light of approximately 570 nm, 
bacteriorhodopsin-based sensor 20 produces a signal.
The response of a bacteriorhodopsin-based sensor 20 is 
illustrated in FIG. 2. A yellow-green light emitting diode 
(LED) near bacteriorhodopsin-based sensor 20 is cycled on 
and off with a 50% duty cycle (upper graph). When the LED 
is on, bacteriorhodopsin-based sensor 20 develops a charge 
gradient between first electrode 24 and second electrode 26. 
The charge gradient results in a measurable signal in circuit 
30. The signal increases and then peaks after some time 
(lower graph). When the LED is off, the chaige gradient 
diminishes through circuit 30, resulting in a falling signal.
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Bacteriorhodopsin-based sensor 20 is quite robust, and circuit 
3 0 produces a signal that follows the duty cycle of the LED for 
hours.
Layer of purple membrane 21 may be “wet” or “dry.” 
“Wet” layer of purple membrane 21 implies that the mem­
brane is in an aqueous environment. Aqueous environments 
are achieved by building pools or trapped spaces into the 
sensor. The pools and trapped spaces must be liquid-tight to 
avoid shorting-out electronic components.
In other embodiments, it is possible to evaporate the liquid 
from the membrane to produce a “dry” layer of purple mem­
brane 21. Surprisingly, dry membrane layers maintain their 
charge transfer characteristics, and may be stable for months. 
Dry membranes allow for easier interfacing to electronic 
components. However, producing a functional wet bacterior­
hodopsin-based sensor 20 is easier than constructing a dry 
bacteriorhodopsin-based sensor 20 because the membrane 
layer is more stable in an aqueous environment.
As shown in FIG. 1, bacteriorhodopsin-based sensor 20 
may be further functionalized by placing fluorophores 28, in 
proximity to layer of purple membrane 21. Fluorophores 28 
useful for the invention absorb light with wavelengths shorter 
than 570 nm, typically ultraviolet light, and then transfer 
some of the energy of the absorbed light to layer of purple 
membrane 21 via radiative transfer 27 (i.e., fluorescence). 
Thus, absorption of light by fluorophores 28 and emission 
within the absorption band of bacteriorhodopsin will result in 
a change in charge gradient, and ultimately a signal from 
circuit 30. Sensors employing fluorophores will typically use 
a shorter wavelength light to activate the sensor, however the 
response of the sensor to this light is very similar to that 
shown in FIG. 2.
Fluorophores suitable for the invention include, but need 
not be limited to, fluorescent dyes, chromophores, and quan­
tum dots. Fluorophores suitable for the invention typically 
have an emission spectrum overlapping with the absorption 
spectrum of bacteriorhodopsin, as shown in FIG. 3. The 
absorption spectrum of bacteriorhodopsin 30 is rather broad 
with a peak at approximately 570 nm. In contrast, the emis­
sion spectrum of a fluorophore 35 is much narrower. Emis­
sion spectrum 35 corresponds to a quantum dot, specifically 
chosen for its overlapping emission spectrum. The techniques 
for engineering quantum dots to produce a desired emission 
spectrum are known to those of ordinary skill in the art.
In some embodiments, the emission spectrum of the fluo­
rophores may be altered by the presence of targeted chemical 
or biological species. In these embodiments, bacteriorhodop­
sin-based sensor 20 may become a sensitive chemical or 
biological sensor. For example, fluorophore 28 in proximity 
to layer of purple membrane 21 may undergo a conforma­
tional change in the presence of a biological species, resulting 
in an emission spectrum that no longer overlaps with the 
absorption spectrum of bacteriorhodopsin. Alternatively, for 
example, the presence of a chemical species may result in a 
change in the electronic structure of fluorophore 28, thereby 
shifting the emission spectrum of fluorophore 28 from the 
peak of the bacteriorhodopsin absorption spectrum. When a 
binding event causes a shift in the emission spectrum of 
fluorophore 28, the bacteriorhodopsin will not pump as many 
protons across the membrane gradient. The decrease in pro­
ton pumping diminishes the charge gradient between first 
electrode 24 and second electrode 26, thus the signal from 
circuit 30 diminishes. By monitoring for signal drops, it is 
possible to detect a wide range of binding events with extreme 
sensitivity.
In embodiments where fluorophores 28 are quantum dots, 
it is possible to additionally functionalize the quantum dots
5
with receptors 29 that bind targeted chemical or biological 
species. Targeted biological species may include, but need not 
be limited to, antibodies, antigens, proteins, nucleic acids, 
enzymes, and lipids. Targeted chemical species may include, 
but need not be limited to, antigens, hormones, small mol­
ecules, drugs, drug candidates, alkanes, alkenes, alkynes, and 
aromatic species, as well as substituted alkanes, alkenes, 
alkynes, and aromatic species. For example, a quantum dot 
may be functionalized with an antibody. In the presence of 
light, and in the absence of an antigen that binds that antibody, 
the quantum dots emit light that overlaps the absorption spec­
trum of bacteriorhodopsin, producing a signal from circuit 
30. When the antibody binds an antigen, however, the emis­
sion spectrum of the quantum dot shifts, resulting in a change 
in the signal of circuit 30. In other embodiments, the emission 
of fluorophore 28 may be quenched completely, resulting in 
no signal.
The invention is not limited to the use of antibodies as 
receptors, however. For example, quantum dots may also be 
functionalized with the substrate recognition region of an 
enzyme, or with a binding protein, or with a nucleic acid 
aptamer. Receptors may be adapted from known biological 
structures or new receptors may be specifically developed for 
a sensor of the invention via combinatorial screening or com­
puter-aided design.
Receptors need not be incorporated into, or attached to, the 
fluorophore, however. The invention also includes receptors 
incorporated into linker molecules or linkages (discussed 
below). Such receptors may be sensitive to antibodies, anti­
gens, proteins, nucleic acids, enzymes, lipids, hormones, 
small molecules, drugs, drug candidates, alkanes, alkenes, 
alkynes, or aromatic species, as well as substituted alkanes, 
alkenes, alkynes, or aromatic species Receptors may be addi­
tionally incorporated into the bacteriorhodopsin or lipids of 
the purple membrane using known techniques of genetic 
engineering and chemical synthesis. In view of this disclo­
sure, one of skill in the art of molecular biology should be able 
to develop a number of sensors specific to the particular 
chemical or biological species of interest.
In embodiments where fluorophores 28 are quantum dots, 
it may be additionally beneficial to use linker molecules to 
keep fluorophores 28 in proximity to layer of purple mem­
brane 21 so that light emitted from fluorophores 28 is cap­
tured by the bacteriorhodopsin in layer of purple membrane 
21. Linker molecules may include, but need not be limited to, 
long-chain organic molecules comprising at least one carbon- 
carbon double bond. Such long-chain hydrocarbons may 
include unsaturated fats and/or surfactants. Linker molecules 
may also comprise oligomers of organic molecules or nucleic 
acids. In some embodiments, the linker molecules may be 
streptavidin-biotin constructs. In some embodiments, the 
linker molecules may be 1 -ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC). Linker molecules addi­
tionally may be functionalized with receptors such that the 
linker molecules will undergo conformational changes result­
ing in a change in distance between layer of purple membrane 
21 and fluorophores 28.
The principles of the invention may be used to produce 
bacteriorhodopsin-based transistor sensors. A generalized 
bacteriorhodopsin-based transistor sensor 40 is shown in 
FIG. 4. Rather than using two electrodes and measuring a 
change in charge gradient across layer of purple membrane 
21, transistor sensor 40 measures variations in the charge 
density of the cytoplasmic side of layer of purple membrane 
21 via a gate 41 of a simple semiconductor field effect tran­
sistor (FET).
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One embodiment is represented in FIG. 4. The FET is 
comprised of gate 41, source 42, drain 43, and body 44. 
Similar to FIG. 1, layer of purple membrane 21 may be 
directly deposited on the metal surface of gate 41. For tran­
sistor sensors 40, layer of purple membrane 21 is typically 
dried once it is attached to gate 41. The surface area of layer 
of purple membrane 21 in transistor sensor 40 is typically less 
than about 10 pmxlO pm, preferably less than about 5 pmx5 
pm. The FET is provided with an external power source (not 
shown). Source 42 and drain 43 are attached to a circuit 45, 
allowing the potential at gate 41 to be measured as a function 
of time. Circuit 45 may comprise an oscilloscope, a personal 
digital assistant, or a personal computer, for example. When 
transistor sensor 40 is exposed to light 46 from an LED 47, the 
change in charge density at gate 41 will result in a signal from 
circuit 45. Modulating the output of LED 47 will result in a 
modulated signal, as shown in FIG. 2.
FETs suitable for the bacteriorhodopsin-based transistor 
sensors 40 of the invention may be created using techniques 
known to those of average skill in the art. Additionally one of 
skill in the art will be capable of fabricating many FETs on a 
singular substrate and wiring and powering the FETs indi­
vidually to create arrays of FETs. One of average skill in the 
art will also be capable of protecting the subcomponents of 
the FETs (e.g., withresins) from the solutions used to perform 
additional processing steps, including the deposition of layers 
of purple membrane.
In another embodiment, monolayers of purple membrane 
may be deposited atop the gate of an FET with an exposed 
metal gate using ionic self-assembled monolayer films. 
Monolayer deposition may be accomplished by rinsing gate 
41 in a strong base to render a net negative charge on the gate, 
then dipping gate 41 into a solution of poly(dimethyldially- 
lammonium) chloride to produce a surface of positive charge, 
and then dipping gate 41 into a solution of purple membrane. 
Typically, a deposition time of 5 minutes will yield a single 
monolayer of purple membrane, i.e., bacteriorhodopsin pro­
teins arranged in a singular lipid bi-layer, as depicted in FIG.
4. Typically, a slide strainer is used for the dip steps, however 
other methods of depositing films are known to those of 
average skill the relevant art. In this embodiment, the poly 
(dimethyldiallylammonium) chloride acts as an adhesion 
spacer layer. Other adhesion spacer layer species may be 
substituted for poly(dimethyldiallylammonium) chloride.
In other embodiments, monolayers of purple membrane 
may be deposited without an adhesion spacer layer by 
directly dipping the gate into a prepared film of purple mem­
brane, e.g., using Langmuir-Blodgett (L-B) techniques. After 
building up the desired number of monolayers using L-B, it is 
then possible to functionalize the purple membrane layers 
with additional L-B films, which may optionally contain fluo- 
rophores and/or receptors.
While one monolayer of purple membrane will produce 
functional sensors, in other embodiments it may be beneficial 
to deposit multiple monolayers of purple membrane. Mul­
tiple monolayers may be achieved through iterative dipping in 
poly(dimethyldiallylammonium) chloride and purple mem­
brane solutions, or through iterative dipping in an L-B trough 
without the poly (dimethyldiallylammonium). Bacterior­
hodopsin-based transistor sensors 40 of the invention will 
typically have less than 10 monolayers of purple membrane, 
or less than 5 monolayers of purple membrane, more typically 
only 2 or 1 monolayers of purple membrane.
Using alternative adhesion spacer layer species, such as 
polystyrene sulfonate, it is possible to deposit the extracellu­
lar side of layer of purple membrane 21 to gate 41 to produce 
transistor sensor 40. Attaching the extracellular side of layer
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of purple membrane 21 to gate 41 will result in a different bias 
for gate 41. Depending upon the application for transistor 
sensor 40, a reversed gate 41 bias may be beneficial.
Layer of purple membrane 21 in transistor sensor 40 may 
be functionalized with fluorophores 28, as shown in FIG. 5 to 
create a chemical/biological transistor sensor 50. Like tran­
sistor sensor 40, chemical/biological transistor sensor 50 
comprises layer of purple membrane 21, a FET comprising 
gate 41, source 42, drain 43, body 44, and circuit 45 for 
measuring the potential at gate 41. Chemical/biological tran­
sistor sensor 50 further comprises fluorophores 28 attached to 
layer of purple membrane 21. Fluorophores 28 may be 
attached by depositing additional layers of poly(dimethyl- 
diallylammonium) chloride atop the monolayer(s) of purple 
membrane, and then dipping the poly(dimethyldiallylammo- 
nium) chloride-coated structure in fluorophores 28 having a 
negative charge. Fluorophores 28 may also be attached with 
linker molecules such as linkages 51. When chemical/bio­
logical transistor sensor 50 is exposed to shorter wavelength 
light 54, from light source 56, fluorophores 28 will absorb 
shorter wavelength light 54, and re-emit longer wavelength 
light (not shown) that coincides with absorption spectrum of 
bacteriorhodopsin 30, shown in FIG. 3. Shorter wavelengths 
of light, suitable for activating sensors of the invention, typi­
cally comprise light of wavelengths shorter than 570 nm.
Linkages 51 and or adhesion spacer layers are necessary to 
keep fluorophores 28 in proximity to layer of purple mem­
brane 21 so that light emitted from fluorophores 28 is cap­
tured by the bacteriorhodopsin in layer of purple membrane 
21. Linkages may include, but need not be limited to, long- 
chain organic molecules comprising at least one carbon-car­
bon double bond. Such long-chain hydrocarbons may include 
unsaturated fats and/or surfactants. Linkages may also com­
prise oligomers of organic molecules or nucleic acids. In 
some embodiments, the linkages may comprise streptavidin- 
biotin constructs. Linkages 51 may also comprise l-ethyl-3- 
(3-dimethylaminopropyl) carbodiimide hydrochloride 
(EDC). Linkages 51 may additionally be functionalized with 
receptors such that linkages 51 will undergo conformational 
changes resulting in a change in distance between layer of 
purple membrane 21 and fluorophores 28.
In some embodiments, linkages 51 may be directly bound 
to layer of purple membrane 21. Direct binding is possible by 
using streptavidin-biotin constructs, for example. First, bac­
teriorhodopsin is biotinylated by mixing biotin into a suspen­
sion of purple membrane fragments in 0.1 M sodium bicar­
bonate buffer (pH of about 8.5). During mixing, the biotin 
attaches to lysine residue 129 in the bacteriorhodopsin pro­
tein. Next, the purple membrane fragments can be reas­
sembled into layer of purple membrane 21 by using mem­
brane assembly techniques, including, but not limited to, 
electrophoretic sedimentation. Then fluorophore 28 is func­
tionalized with streptavidin using techniques known to those 
of average skill in the art. Finally, when streptavidin-func- 
tionalized fluorophores 28 are deposited onto layer of purple 
membrane 21, the streptavidin binds to the biotin functional­
ized bacteriorhodopsin, resulting in linkage 51 between layer 
of purple membrane 21 and fluorophore 28.
In addition to keeping fluorophores 28 bound to layer of 
purple membrane 21, it is preferably that linkages 51 main­
tain a specific distance between fluorophores 28 and the bac­
teriorhodopsin in layer of purple membrane 21 to maximize 
the signal produced as a result of a change in distance between 
fluorophore 28 and layer of purple membrane 21. As has been 
well-described (Lakowicz, Principles o f  Fluorescence Spec­
troscopy (1999)) the efficiency of non-radiative energy trans­
fer (Forster eneigy transfer) is a function of the distance
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between fluorophore 28 and the bacteriorhodopsin in layer of 
purple membrane 21. This phenomenon is known broadly as 
Fluorescence Resonance Energy Transfer (FRET). The rela­
tionship between distance and non-radiative transfer is given 
by
i } 06=( 8.8X1023 mol)(K2)(nD4)(<S>D)(J(X))) (I)
where R0 is the distance at which 50% of the donor’s energy 
is transferred non-radiatively, K is the dipole orientation fac­
tor, r\D is the refractive index of the medium, <bD is the quan­
tum yield of the donor, and J is the normalization overlap 
integral between the donor and acceptor at the specific wave­
length X. Thus the efficiency, E, of the non-radiative energy 
transfer is indicative of R, the distance between fluorophore 
28 and the bacteriorhodopsin in layer of purple membrane 21.
The efficiency of the non-radiative energy transfer is 
described by equation 11.
9
Rf (II)
E  = ____0__
R^+R6
Because of conservation of energy, an increase in the effi­
ciency of non-radiative energy transfer results in a consumate 
decrease in the efficiency of radiative energy transfer. 
Because bacteriorhodopsin only produces a charge gradient 
in the event of radiative energy transfer (i.e. fluorophore fluo­
rescence), a decrease in distance between fluorophores 28 and 
the bacteriorhodopsin in layer of purple membrane 21, should 
result in a decreased signal measured by circuit 45.
The relationship between non-radiative eneigy transfer and 
distance produces a characteristic curve, like the one shown in 
FIG. 12C. (The curve in FIG. 12C is for the 565 nm emission- 
center quantum dot and bacteriorhodopsin system exempli­
fied below.) As can be seen in FIG. 12C, there is an inflexion 
point at approximately 7.6 nm of separation between the 
quantum dot and the retinal molecule in the bacteriorhodop­
sin. Thus, at 7.6 nm of separation, small changes in distance 
result in dramatic changes in non-radiative transfer. Typi­
cally, sensors of the invention are engineered to have the 
separation between fluorophore 28 and layer of purple mem­
brane 21 at approximately the inflexion point of the curve in 
the absence of targeted chemical or biological species.
Like the embodiments described above with respect to 
FIG. 1, the emission spectrum of fluorophores 28 may be 
altered by the presence of a chemical or biological species. 
For example, fluorophore 28 linked to layer of purple mem­
brane 21 may undergo a conformational change in the pres­
ence of a biological species, resulting in an emission spec­
trum that no longer overlaps with absorption spectrum of 
bacteriorhodopsin 30. Alternatively, for example, the pres­
ence of a chemical species may result in a change in the 
electronic structure of fluorophore 28, thereby shifting emis­
sion spectrum 35 of fluorophore 28 from the peak of the 
bacteriorhodopsin absorption spectrum. Similar to the 
embodiments described with respect to FIG. 1, when a bind­
ing event causes a shift in the emission spectrum of fluoro­
phore 28, the bacteriorhodopsin will not pump as many pro­
tons across the membrane gradient. The decrease in proton 
pumping diminishes the charge density at gate 41, thus the 
signal from circuit 45 diminishes. In other embodiments, the 
emission of fluorophore 28 may be quenched completely.
In embodiments where fluorophores 28 are quantum dots, 
it is possible to additionally functionalize the quantum dots 
with receptors 29 that bind targeted chemical or biological 
species. Receptors 29 may comprise antibodies, for example.
In the presence of shorter wavelength light 54, and in the 
absence of an antigen that binds to the antibody, the quantum 
dots emit light that overlaps the absorption spectrum of bac­
teriorhodopsin, producing a signal from circuit 45. When the 
antibody binds an antigen, however, the emission spectrum of 
the quantum dot shifts, resulting in a change in the signal of 
circuit 45.
The relationship between distance and efficiency of non- 
radiative transfer provides another mechanism for activating 
chemical/biological transistor sensor 50. Linkages 51 may be 
engineered such that linkages 51 have receptors for targeted 
chemical or biological species. In the presence of the targeted 
chemical or biological species, linkages 51 undergo a confor­
mational change, thus bringing fluorophores 28 closer to 
layer of purple membrane 21. When fluorophores 28 move 
closer to layer of purple membrane 21, the amount of non- 
radiative energy transfer increases, resulting in a smaller 
charge density at gate 41, and a decreased signal from circuit 
45. It is also possible that targeted chemical and/or biological 
binding events will result in the severance or detachment of 
linkages 51. The severance or detachment of linkages 51 will 
also result in a diminished signal from circuit 45.
Methods of using the sensors of the invention for the detec­
tion and quantification of targeted chemical or biological 
species are straightforward. In embodiments where the goal is 
merely to detect targeted chemical or biological species, it 
may be sufficient to merely contact the sensor with a sample, 
in the presence of shorter wavelength light, and observe the 
signal for a change. This method may be beneficial for toxin 
detection, for example, wherein any presence of the toxin is 
cause for alarm. Samples may include, but need not be limited 
to, bodily fluids, municipal water, air, process fluids, combus­
tion effluent, groundwater, fuels, and foods.
In other embodiments where the goal is to quantify an 
amount of targeted chemical or biological species, it may be 
necessary to calibrate the sensor ahead of time using calibra­
tion samples having known quantities of targeted chemical or 
biological species. By presenting a plurality of samples with 
known amounts of targeted chemical or biological species 
and recording the signal for each calibrated sample, it is 
possible to construct a correlation that can be used to quantify 
an amount of targeted chemical or biological species in a 
sample. For example, five calibration samples may be pre­
sented to the sensor, resulting in five different signals. The 
signals of the five calibration samples may be correlated to 
known amounts of targeted chemical or biological species 
using a least-squares fitting function. The correlation result­
ing from the least-squares fitting function can be used to 
quantify amounts of targeted chemical or biological species 
in samples based upon the signal. Other methods of correlat­
ing signal to amount are known to those of skill in the art.
EXAMPLES
The following non-limiting examples further illustrate the 
sensors of the invention.
Example 1
Preparation of Oriented Purple Membrane
The process of preparing and purifying bacteriorhodopsin 
for engineered applications has been described (Stuart, 
Preparation, purification and modification of bacteriorhodop­
sin for use in protein-based optical devices). In brief, the 
Halobacterium salinarium cells were grown at 40° C. in a 
basal salts medium containing bacteriological peptone. Once
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grown to a desired density, the cells were collected by cen­
trifugation at 17,700 g for 10 minutes. The collected cells 
were then lysed through the addition of deionized water. The 
released nucleic acids were digested with 1 -3 Units/ml, final 
solution volume, of DNase I. The laiger cell debris was col­
lected through centrifugation at 3,000 g for 5 minutes. Purple 
membrane (bacteriorhodopsin and associated lipids) 
remained in the supernatant and was separated from the red 
membrane by centrifugation at 105,000 g for 30 minutes. The 
purple membrane was pelleted in this centrifugation step, 
which was repeated until the supernatant was clear. For addi­
tional purification, the purple membrane was passed over a 
linear sucrose gradient. The purity of the resulting bacterior­
hodopsin preparation was evaluated by sodium dodecyl sul­
fate-polyacrylamide gel electrophoresis (SDS-PAGE) on a 
12% Bis-Tris gel.
Purple membrane layer for a sensor was created using 
electrophoretic sedimentation (EPS) as shown in FIG. 6. This 
method provides a layer of purple membrane comprising 
highly-orientated bacteriorhodopsin, e.g., the cytoplasmic 
ends of the bacteriorhodopsin are identically-oriented. A fix­
ture 60 was constructed to hold substrate 25 (glass slide) with 
first electrode 24, and a brass electrode 62 apart, with a 
separation distance of approximately 1 mm. The distance of 
separation is not critical, and the EPS will work with larger 
and smaller separations. First electrode 24 (positive elec­
trode) is a sputtered layer of optically transparent and elec­
trically conductive indium tin oxide (ITO) on substrate 25. 
The dimensions of the slide (25) were 5 mmxlO mm and 
electrode 24 had a sheet resistance of 5-10Q. Thirty pi of 
suspension 64 of 15 mg/ml purple membrane in distilled/ 
deionized water (ddl) water was pipetted on top of first elec­
trode 24 and substrate 25. The brass electrode 62 (negative 
electrode) was placed on top with 1 mm spacing between the 
electrodes. An electric field of 40 V/cm was applied between 
the electrodes for 1 minute, as depicted in FIG. 6. It was 
possible to visually observe layer of purple membrane 21 
deposit out of suspension 64 and attach to first electrode 24 
while the electric field was being applied.
Following the 1 minute exposure to the electric field, the 
top brass electrode 62 was removed and the excess water was 
pipetted off layer of purple membrane 21. First electrode 24 
with attached layer of purple membrane 21 was then rinsed 
for 10 seconds in a beaker of distilled/deionized water to 
remove any weakly attached purple membrane. First elec­
trode 24 with attached layer of purple membrane 21 was then 
stored in a humidity chamber for 24 hours to dry. Flumidity in 
the chamber was maintained at -52% through the use of a 
magnesium nitrate salt solution. The dimensions of substrate 
25 with attached first electrode 24 with attached layer of 
purple membrane 21 was approximately 5 mmx5 mm with a 
thickness of layer of purple membrane 21 of approximately
20 pm measured with an interferometric microscope.
For applications which require a wet layer (aqueous sus­
pension) of layer of purple membrane 21, a glass slide 73 with 
second electrode 26 (also indium-tin-oxide) may be placed 
atop a prior assembly of substrate 25, electrode 24, and layer 
of purple membrane 21 after rinsing (above) but before dry­
ing (above), as shown in FIG. 7 (a). In order to maintain the 
aqueous environment, it is necessary to add a spacer 74 
around the perimeter of the layer of layer of purple membrane
21 in order to keep layer of purple membrane 21 wet. Spacer 
74 may be, for example, a rubber O-ring. The resulting con­
struct is hereafter a wet assembly 72.
Alternatively, some applications require dry layer of purple 
membrane 21. For these applications, substrate 25 with 
attached first electrode 24 with attached layer of purple mem­
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brane 21 can be dried as described above and shown in FIG. 
6, and the resulting layer of purple membrane 21 sputtered 
with a layer of gold to create second electrode 26, to create the 
structure shown in FIG. 7 (b). The resulting construct is 
hereafter a dry assembly 76.
A representative circuit 30 capable of producing a signal in 
response to a charge gradient across layer of purple mem­
brane 21 is shown in FIG. 8. Circuit 30 can measure a change 
in voltage (AV) between first electrode 24 and second elec­
trode 26 in either wet assembly 72 or dry assembly, and 
amplify the AV for recording by an oscilloscope or computer. 
Circuit 30 comprises an operational amplifier, resistors, and 
capacitors as necessary to reduce noise and achieve the 
desired amplification of the AV between first electrode 24 and 
second electrode 26. Electronic circuit 30 shown in FIG. 8 
acts as a xlO amplifier, however other amplifications are 
possible and the modifications necessary to achieve alternate 
amplifications are known to those of skill in the art. For the 
experiments shown herein, bacteriorhodopsin-based sensor 
20 and circuit 30 were placed inside a Faraday cage to reduce 
RF noise. Circuit 30 was powered by a triple output voltage 
supply (F1P 6237A, Agilent Technologies, Santa Clara, 
Calif.). The output signal from circuit 30, Vou„ was run 
through a low-frequency noise filter (Krohn-Flite 3364, 
Krohn-Flite, Brockton, Mass.). After filtering, the condi­
tioned signal is sent into a 60 MFlz, 200 MSa/s oscilloscope 
(Agilent 54621D, Agilent Technologies, Santa Clara, Calif.) 
for analysis.
Example 2
Addition of Quantum Dot Layer to Wet Assembly
Quantum dots (Evident Technologies, Troy, N.Y.) having 
an emission band centered at 565 nm were chosen to maxi­
mize the overlap between quantum dot fluorescence spectrum 
35 and bacteriorhodopsin absorption spectrum 30. This over­
lap is depicted in FIG. 3.
FIG. 9A shows a completed quantum dot, bacteriorhodop­
sin-based optical sensor 90 with circuit 3 0 removed. A well 91 
was formed by placing a rubber gasket 92 around the perim­
eter of the back side of glass slide 73 of wet assembly 72. A 40 
pL volume of 63 nmol/L quantum dot suspension 93 was 
applied added to well 91. A 310 nm light-emitting diode 
(LED) 94 was arranged at an angle so that LED 94 would 
illuminate the layer of quantum dots with UV light 95, with 
minimal direct exposure of the bacteriorhodopsin in layer of 
purple membrane 21. With LED 94 flashing at approximately 
4 Flz, the quantum dots were visibly activated, and their 
photonic emission resulted in a AV and corresponding peaks 
99, as shown in FIG. 9B. The periodic peaks 99 generated 
from bacteriorhodopsin-based optical sensor 90 directly cor­
related to the flashing of the LED 94.
Example 3
Addition of Quantum Dot Layer to Dry Assembly
Dry assembly 76 was prepared as described above. A 63 
nmol/L suspension of quantum dots was pipetted upon the 
second electrode 26, and the quantum dot suspension is 
allowed to dry. A semiconductor parameter analyzer was used 
in lieu of the low-frequency noise filter and oscilloscope in 
order to increase sensitivity.
Dry assembly 76 with quantum dots, and without quantum 
dots, were compared to judge the signal boost gained from the 
addition of the quantum dots. As in previous examples, the
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sensors were exposed to flashing LEDs. FIG. 10 shows a 
comparison of the UV-light sensitivity of dry assembly 76 
before 102, and after 103, the deposition of the quantum dots. 
As can be seen from FIG. 10, there are some small peaks 106 
attributable to the flashing LED before 102 the quantum dots 
are deposited. However, the signal peaks 108 increased nearly 
an order of magnitude once the quantum dots were deposited.
Comparing the signals of “wet” bacteriorhodopsin-based 
optical sensor 90 (FIGS. 9A, B) to “dry” bacteriorhodopsin- 
based optical sensor (FIG. 10), it is clear that the wet sensor 
has a much larger signal output than the dry sensor for similar 
UV-illumination events. This is not surprising, given the dif­
ference in the spacing between layer of purple membrane 21 
and the quantum dot layers in the wet and dry sensors, respec­
tively. As seen in FIG. 12A, the spacing between layer of 
purple membrane 21 and quantum dots in the “wet” sensor is 
approximately 1 mm, corresponding to the thickness of glass 
slide 73. As seen in FIG. 12B, the spacing between layer of 
purple membrane 21 and quantum dots in the dry sensor is 
approximately 4 nm, the thickness of second electrode 26. 
Again, because of the relationship between distance and non- 
radiative transfer, illustrated in FIG. 12C, it is expected that 
signal due to radiative energy transfer would be smaller in the 
“dry” sensor where the quantum dots and the bacteriorhodop- 
sin are close together.
Example 4
Preparation of Thin Oriented Purple Membrane
The fabrication methods described in Example 1 produce 
oriented purple membranes on the order of 20 pm thick. 
However, in order to take advantage of changes in radiative 
versus non-radiative energy transfer, it is necessary to pro­
duce oriented purple membranes on the order of tens of 
nanometers thick, preferably one monolayer of purple mem­
brane (e.g., comprising only bacteriorhodopsin and a singular 
lipid bilayer). As in Example 1, Halobacterium salinarium 
cells were grown at 40° C. in a basal salts medium containing 
bacteriological peptone. Once grown to a desired density, the 
cells were collected by centrifugation at 17,700 g for 10 
minutes. The collected cells were then lysed through the 
addition of deionized water. The released nucleic acids were 
digested with 1 -3 Units/ml, final solution volume, of DNase I. 
The larger cell debris was collected through centrifugation at 
3,000 g for 5 minutes. Purple membrane (bacteriorhodopsin 
and associated lipids) remained in the supernatant and was 
separated from the red membrane by centrifugation at 105, 
000 g for 30 minutes. The purple membrane was pelleted in 
this centrifugation step, which was repeated until the super­
natant was clear. For additional purification, the purple mem­
brane was passed over a linear sucrose gradient. The purple 
membrane was then suspending in distilled deionized water.
An electrode of indium tin oxide was deposited on a sub­
strate. The substrate with electrode was coated with poly 
(dimethyldiallylammonium) chloride using a Langmuir- 
Blodgett trough, to produce a surface-charged electrode­
substrate assembly. When the surface-charged electrode­
substrate assembly was soaked in a purple membrane 
suspension for approximately 5 minutes, a monolayer of ori­
ented purple membrane was deposited upon the electrode. 
When allowed to dry under controlled humidity, the resultant 
monolayer of oriented purple membrane was quite robust.
Example 5
Thin Oriented Purple Membrane—Quantum Dot 
Light Sensor
Using the techniques described in Example 4, a monolayer 
of oriented purple membrane was deposited upon an indium
13
tin oxide (ITO) electrode atop a substrate. In an iterative 
fashion, a layer of poly(dimethyldiallylammonium) was 
deposited upon the first monolayer of purple membrane, then 
a second layer of purple membrane was deposited upon the 
layer of poly(dimethyldiallylammonium), then a layer of 
poly(dimethyldiallylammonium) was deposited upon the 
second monolayer of purple membrane, then a third layer of 
purple membrane was deposited upon the layer of poly(dim- 
ethyldiallylammonium). The third monolayer of purple 
membrane was biotinylated prior to deposition by mixing 
biotin into a suspension of purple membrane fragments in 0.1 
M sodium bicarbonate buffer (pH of about 8.5). After the 
purple membrane monolayers were deposited, a platinum 
wire was placed in proximity to the purple membrane mono- 
layers, and two drops of 0.1 M KC1 were added to assure 
electrical contact. The ITO electrode and platinum wire were 
then attached to a xlO preamp and oscilloscope. When a 
Xenon lamp was switched on, a peak was visible on the 
oscilloscope, which decayed away in approximately 2 sec­
onds. When the Xenon lamp was switched off, a negative 
peak was visible. See FIG. 11, “no QD.”
The platinum wire was then removed, the KC1 pipetted 
away, and the purple membrane layers washed with D1 water. 
The assembly was then incubated with 0.5 nmol/ml strepta- 
vidin-coated quantum dots (595 nm emission center) for 15 
minutes. After the incubation period the assembly was rinsed 
for 2 minutes in D1 water to remove any unbound quantum 
dots. The platinum wire was replaced, two drops of KC1 
solution were added, and the sensor reattached to the preamp 
and oscilloscope. As can be seen in FIG. 11 the resulting 
sensor had a similar response to the Xenon light, however the 
amplitude of the response was greater. See FIG. 11, “QD.” 
The response was greater because the quantum dots allowed 
the bacteriorhodopsin in the purple membrane to use a greater 
number of the photons emitted from Xenon light spectrum. 
That is, some of the photons that were too energetic to be 
captured by the bacteriorhodopsin were transferred to the 
bacteriorhodopsin via the quantum dots.
Prophetic Examples 
Example 6 
Maltose Sensor
A maltose sensor according to the invention is depicted in 
FIG. 13. The maltose sensor will begin with a dry assembly 
such as that described in Example 1. Using biotin-streptavi- 
din linkages, a layer of quantum dots 121 will be added to the 
gold electrode of dry assembly 76. The distance R, between 
the quantum dots 128 and layer of purple membrane 21 will 
be selectively fixed at approximately 8 nm by linking quan­
tum dots 121 directly to second electrode 26, as seen in FIG. 
13A.An8nmseparationbetween quantum dots 121 andlayer 
of purple membrane 21 will result in the greatest sensitivity of 
the sensor to changes in distance due to binding of chemical 
species.
As shown in FIG. 13 A, the dry sensor will be prepared with 
a second electrode 26 of sputtered gold. The sputtered gold 
surface will be biotinylated with biotin 122 using known 
techniques. Quantum dots 121 will be coated with a single 
monolayer of streptavidin 124. When biotinylated second 
electrode 26 is exposed to streptavidin-coated quantum dots 
121, the quantum dots will self-assemble at a distance 
approximately 8 nm from layer of purple membrane 21. The
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quantum dot-linked dry assembly 126 will then be washed 
with distilled deionized water to remove the excess quantum 
dots 121.
As shown in FIG. 9B-D, quantum dot-linked dry assembly 
126 becomes the basis for a maltose sensor. Quantum dot- 
linked dry assembly 126 will be washed with biotin coated 
maltose-binding protein 127 (FIG. 13B). The assembly 
shown in FIG. 13B will give a consistent signal upon illumi­
nation with UV-light, as shown previously in FIGS. 9B and 
10, because the distance between quantum dots 121 and layer 
of purple membrane 21 is approximately 8 nm. Fiowever, 
when a (3-CD-QSY9 dark quencher 128 is introduced to mal­
tose binding protein 127, dark quencher 128 occupies the 
binding site that would otherwise be taken by maltose. (See 
FIG. 13C.) Because dark quencher 128 essentially short- 
circuits the radiative energy transfer pathway, there is no 
signal from the sensor. Upon introduction of maltose 129, 
dark quencher 128 is displaced, re-establishing the radiative 
energy transfer pathway for quantum dots 121, as shown in 
FIG. 13D. Once the radiative energy transfer pathway is 
re-established, a signal will be produced by the sensor. Thus, 
the sensor in FIG. 13 is silent until maltose is present, at which 
point the sensor produces a signal.
Example 7 
Antibody Sensor
An antibody sensor according to the invention is described 
in FIG. 14. Instead of functionalizing quantum dots 121 as in 
FIG. 13, linkages 133 are functionalized with antigens 135 
specific to antibodies 137 of interest. Absent antibody 137, 
quantum dots 121 are maintained 8 nm from layer of purple 
membrane 21 because of linkages 133. Again, as shown in 
FIG. 12C, when quantum dots 121 and layer of purple mem­
brane 21 are separated by more than 8 nm, there is little 
non-radiative transfer. Thus, circuit 30 (not shown) produces 
large signals in the absence of non-radiative transfer. Fiow­
ever, when antibody 137 is introduced, antibody 137 will 
cause a conformational change in linkage 133, bringing quan­
tum dots 121 closer to layer of purple membrane 21. As 
quantum dots 121 move closer to layer of purple membrane 
21, the amount of non-radiative transfer increases, and there­
fore, the signal decreases. Thus, the sensor in FIG. 14 will 
produce a signal until the introduction of antibody 137, at 
which time the signal will decrease.
Example 8
Chemical Sensor Array
A chemical sensor array 140 will be constructed from a 
field of FETs prepared on a silicon chip using known semi­
conductor fabrication techniques. Chemical sensor array 140 
is depicted in FIG. 15. Chemical sensor array 140 will have 
four groups 142 of 144 FETs. (Each FET 143 is a separate 
source, drain, gate, body arrangement as shown in FIGS. 4 &
5.) Using iterative photolithographic techniques, the gates of 
the FETs 143 in each of the four separate groups 142 will be
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exposed and activated, so that the gates in that region will 
receive one or more monolayers of oriented purple mem­
brane. A solution of quantum dots with functionalize linkages 
will then be introduced to the sensor, resulting in 144 FET 
sensors similar to those described in FIG. 5 and FIG. 14. After 
the first group of 144 FETs has been transformed into chemi­
cal sensors, the second group of FETs will be transformed. 
Fiowever, this group will have functionalized linkages that are 
specific to a different chemical target. In an iterative fashion, 
the third and fourth FET groups are converted to chemical 
sensors. The finished chemical sensor array 140 will have 576 
total chemical sensors. The finished chemical sensor array 
140 will be sensitive to four different chemical species.
Thus, the invention provides, among other things, a bacte- 
riorhodopsin-based sensor capable of detecting chemical and 
or biological species. Various features and advantages of the 
invention are set forth in the following claims.
We claim:
1. A sensor comprising:
a substrate;
a first electrode in contact with the substrate;
a membrane adjacent to the first electrode, wherein the 
membrane comprises bacteriorhodopsin;
a second electrode adjacent to the membrane, wherein 
charge is transferred between the first and second elec­
trodes when the membrane is exposed to visible light; 
and
a circuit operatively connected to the first and second elec­
trodes, wherein the circuit produces a signal when 
charge is transferred between the first and second elec­
trodes;
wherein the sensor comprises a fluorophore adjacent to the 
second electrode and the fluorophore transfers energy to 
the membrane when the fluorophore is exposed to light 
with a wavelength shorter than 570 nm.
2. The sensor of claim 1, wherein the membrane is purple 
membrane.
3. The sensor of claim 2, wherein the purple membrane is 
wet.
4. The sensor of claim 2, wherein the purple membrane is 
dry.
5. The sensor of claim 1, wherein the fluorophore is 
attached to the membrane with a linker molecule.
6. The sensor of claim 5, wherein the linker molecule is a 
biotin-streptavidin construct.
7. The sensor of claim 1, wherein the energy transfer 
between the fluorophore and the membrane comprises a 
radiative process.
8. The sensor of claim 1, wherein the energy transfer 
between the fluorophore and the membrane comprises a non- 
radiative process.
9. The sensor of claim 1, wherein the fluorophore is a 
quantum dot.
10. The sensor of claim 9, wherein the quantum dot is 
functionalized.
11. The sensor of claim 10, wherein the functionalized 
quantum dots are functionalized with receptors that bind tar­
geted chemical or biological species.
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